- Home
- CATO vs VRCA Comparison
CATO vs VRCA Comparison
Compare CATO & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATO
- VRCA
- Stock Information
- Founded
- CATO 1946
- VRCA 2013
- Country
- CATO United States
- VRCA United States
- Employees
- CATO N/A
- VRCA N/A
- Industry
- CATO Clothing/Shoe/Accessory Stores
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- CATO Consumer Discretionary
- VRCA Health Care
- Exchange
- CATO Nasdaq
- VRCA Nasdaq
- Market Cap
- CATO 59.2M
- VRCA 54.0M
- IPO Year
- CATO N/A
- VRCA 2018
- Fundamental
- Price
- CATO $2.87
- VRCA $0.65
- Analyst Decision
- CATO
- VRCA Hold
- Analyst Count
- CATO 0
- VRCA 5
- Target Price
- CATO N/A
- VRCA $6.00
- AVG Volume (30 Days)
- CATO 43.0K
- VRCA 630.2K
- Earning Date
- CATO 08-21-2025
- VRCA 08-13-2025
- Dividend Yield
- CATO 6.11%
- VRCA N/A
- EPS Growth
- CATO N/A
- VRCA N/A
- EPS
- CATO N/A
- VRCA N/A
- Revenue
- CATO $642,949,000.00
- VRCA $7,179,000.00
- Revenue This Year
- CATO N/A
- VRCA $171.87
- Revenue Next Year
- CATO N/A
- VRCA $71.38
- P/E Ratio
- CATO N/A
- VRCA N/A
- Revenue Growth
- CATO N/A
- VRCA N/A
- 52 Week Low
- CATO $2.19
- VRCA $0.38
- 52 Week High
- CATO $6.70
- VRCA $8.98
- Technical
- Relative Strength Index (RSI)
- CATO 53.03
- VRCA 58.18
- Support Level
- CATO $2.73
- VRCA $0.52
- Resistance Level
- CATO $2.99
- VRCA $0.67
- Average True Range (ATR)
- CATO 0.18
- VRCA 0.07
- MACD
- CATO -0.02
- VRCA -0.00
- Stochastic Oscillator
- CATO 30.14
- VRCA 68.10
About CATO Cato Corporation (The)
The Cato Corp operates as a specialty retailer of fashion apparel and accessories in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.